待处理
入排:排除
图源:待检查
Efficacy and safety of bevifibatide in patients with acute coronary syndrome undergoing percutaneous coronary intervention (BES-PCI): A multicenter, randomized, double-blinded, placebo-controlled, phase III trial.
Hongyi Wu, Lili Xu, Lilian Bao, Zhifeng Yao, Xiaomei Guo, Lin Wang, Zhuhua Yao, Qiang Tang, Ying Liu, Xiaoshu Cheng, Ying Guo, Shuiping Zhao, Dongmei Wang, Guangcheng Zhang, Genshan Ma, Luning Zhou, Juying Qian, Junbo Ge, BES-PCI investigators
Chin Med J (Engl) 10.1097/CM9.0000000000003877
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板